Advanced search
Publication Cover
Acta Oncologica Volume 54, 2015 - Issue 2
Journal homepage
3,438
Views
65
CrossRef citations to date
0
Altmetric
Review article

Outcomes of stereotactic radiotherapy for cranial and extracranial metastatic renal cell carcinoma: A systematic review

Gargi KothariDivision of Radiation Oncology and Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, AustraliaCorrespondence[email protected]
,
Farshad ForoudiDivision of Radiation Oncology and Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia;Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia
,
Suki GillDivision of Radiation Oncology and Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
,
Niall M. CorcoranDepartments of Urology and Surgery, Royal Melbourne Hospital and the University of Melbourne, Parkville, Victoria, Australia
&
Shankar SivaDivision of Radiation Oncology and Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia;Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia
Pages 148-157 | Received 17 Feb 2014, Accepted 16 Jun 2014, Published online: 20 Aug 2014

Citations (65)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

A. Mennitto, E. Verzoni, F. Cognetti, R. Miceli, M. Milella, A. Mosca, V. E. Chiuri, A. Bearz, F. Morelli, C. Ortega, F. Atzori, M. Donini, M. Claps, V. Guadalupi, P. Sepe, V. Cappelletti, F. G. de Braud & G. Procopio. (2021) Radical metastasectomy followed by sorafenib versus observation in patients withclear cell renal cell carcinoma: extended follow -up of efficacy results from the randomized phase II RESORT trial. Expert Review of Clinical Pharmacology 14:2, pages 261-268.
Read now
Katrien De Wolf, Karim Vermaelen, Gert De Meerleer, Bart N Lambrecht & Piet Ost. (2015) The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy. OncoImmunology 4:10.
Read now

Articles from other publishers (63)

Liliana Eleonora Semenescu, Ligia Gabriela Tataranu, Anica Dricu, Gheorghe Vasile Ciubotaru, Mugurel Petrinel Radoi, Silvia Mara Baez Rodriguez & Amira Kamel. (2023) A Neurosurgical Perspective on Brain Metastases from Renal Cell Carcinoma: Multi-Institutional, Retrospective Analysis. Biomedicines 11:9, pages 2485.
Crossref
Mariaconsiglia Ferriero, Loris Cacciatore, Mario Ochoa, Riccardo Mastroianni, Gabriele Tuderti, Manuela Costantini, Umberto Anceschi, Leonardo Misuraca, Aldo Brassetti, Salvatore Guaglianone, Alfredo Maria Bove, Rocco Papalia, Michele Gallucci & Giuseppe Simone. (2023) The Impact of Metastasectomy on Survival Outcomes of Renal Cell Carcinoma: A 10-Year Single Center Experience. Cancers 15:13, pages 3332.
Crossref
Michael Christensen & Raquibul Hannan. 2023. Integrating Multidisciplinary Treatment for Advanced Renal Cell Carcinoma. Integrating Multidisciplinary Treatment for Advanced Renal Cell Carcinoma 343 357 .
Nam P. Nguyen, Ahmed Ali, Vincent Vinh-Hung, Olena Gorobets, Alexander Chi, Thandeka Mazibuko, Natália Migliore, Maria Vasileiou, David Lehrman, Mohammad Mohammadianpanah, Seyed Alireza Javadinia, Gokoulakrichenane Loganadane, Trinanjan Basu, Satya Bose, Ulf Karlsson & Huan Giap. (2022) Stereotactic Body Radiotherapy and Immunotherapy for Older Patients with Oligometastases: A Proposed Paradigm by the International Geriatric Radiotherapy Group. Cancers 15:1, pages 244.
Crossref
Austin P.H. Dove, Alex Wells, Wu Gong, Dandan Liu & Austin N. Kirschner. (2022) Evaluation of 5 Fraction Stereotactic Body Radiation Therapy (SBRT) for Osseous Renal Cell Carcinoma Metastases. American Journal of Clinical Oncology 45:12, pages 501-505.
Crossref
Aldo Brassetti, Flavia Proietti, Costantino Leonardo & Giuseppe Simone. (2022) The Value of Metastasectomy in Renal Cell Carcinoma in 2021. Indian Journal of Surgery 84:6, pages 1191-1198.
Crossref
Cem Onal, Ozan Cem Guler, Pervin Hurmuz, Guler Yavas, Burak Tilki, Ezgi Oymak, Cagdas Yavas & Gokhan Ozyigit. (2022) Bone-only oligometastatic renal cell carcinoma patients treated with stereotactic body radiotherapy: a multi-institutional study. Strahlentherapie und Onkologie 198:10, pages 940-948.
Crossref
Michael Christensen & Raquibul Hannan. (2022) The Emerging Role of Radiation Therapy in Renal Cell Carcinoma. Cancers 14:19, pages 4693.
Crossref
Cem Onal, Pervin Hurmuz, Ozan Cem Guler, Guler Yavas, Burak Tilki, Ezgi Oymak, Cagdas Yavas & Gokhan Ozyigit. (2022) The role of stereotactic body radiotherapy in switching systemic therapy for patients with extracranial oligometastatic renal cell carcinoma. Clinical and Translational Oncology 24:8, pages 1533-1541.
Crossref
Mark Mikhail, Kevin J. Chua, Labeeqa Khizir, Alexandra Tabakin & Eric A. Singer. (2022) Role of metastasectomy in the management of renal cell carcinoma. Frontiers in Surgery 9.
Crossref
Eric K. Nguyen, Aly Khan A. Lalani, Sunita Ghosh, Naveen S. Basappa, Anil Kapoor, Aaron R. Hansen, Christian Kollmannsberger, Daniel Heng, Lori A. Wood, Vincent Castonguay, Denis Soulières, Eric Winquist, Christina Canil, Jeffrey Graham, Georg A. Bjarnason, Rodney H. Breau, Frédéric Pouliot & Anand Swaminath. (2022) Outcomes of Radiation Therapy Plus Immunotherapy in Metastatic Renal Cell Carcinoma: Results From the Canadian Kidney Cancer Information System. Advances in Radiation Oncology 7:4, pages 100899.
Crossref
Yue Lang, Xin Tian, Hai-Yue Dong, Xiang-Xiang Zhang, Lan Yu, Ming Li, Meng-Meng Gu, Dexuan Gao & Zeng-Fu Shang. (2022) Black Phosphorus Quantum Dots Enhance the Radiosensitivity of Human Renal Cell Carcinoma Cells through Inhibition of DNA-PKcs Kinase. Cells 11:10, pages 1651.
Crossref
Raquibul Hannan, Michael Christensen, Hans Hammers, Alana Christie, Brendan Paulman, Dandan Lin, Aurelie Garant, Waddah Arafat, Kevin Courtney, Isaac Bowman, Suzanne Cole, David Sher, Chul Ahn, Hak Choy, Robert Timmerman & James Brugarolas. (2022) Phase II Trial of Stereotactic Ablative Radiation for Oligoprogressive Metastatic Kidney Cancer. European Urology Oncology 5:2, pages 216-224.
Crossref
Glenn A. Stewart, William G. Breen, Bradley J. Stish, Trey C. Mullikin, Sean S. Park, Kenneth R. Olivier & Brian A. Costello. (2022) Thoracic Radiotherapy for Renal Cell Carcinoma Metastases: Local Control for the Management of Lung and Mediastinal Disease in the Modern Era. Clinical Genitourinary Cancer 20:2, pages 107-113.
Crossref
Milan Vošmik, Mustafa Aml Banni & Libor Hruška. (2022) The role of radiotherapy in renal cell carcinoma and the potential of its combination with immunotherapy. Onkologie 16:1, pages 16-19.
Crossref
Nicolas Magné & Igor Latorzeff. (2021) Oligometastatic renal cell carcinoma: radiotherapy as a new standard of care?. The Lancet Oncology 22:12, pages 1644-1645.
Crossref
Mohammad Haroon, Paul Sathiadoss, Rebecca M. Hibbert, Satheesh Krishna Jeyaraj, Christopher Lim & Nicola Schieda. (2021) Imaging considerations for thermal and radiotherapy ablation of primary and metastatic renal cell carcinoma. Abdominal Radiology 46:11, pages 5386-5407.
Crossref
Jonathan E. Schoenhals, Osama Mohamad, Alana Christie, Yuanyuan Zhang, Daniel Li, Nirmish Singla, Isaac Bowman, Waddah Arafat, Hans Hammers, Kevin Courtney, Suzanne Cole, Aditya Bagrodia, Vitaly Margulis, Neil Desai, Aurelie Garant, Hak Choy, Robert Timmerman, James Brugarolas & Raquibul Hannan. (2021) Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell Carcinoma. Advances in Radiation Oncology 6:5, pages 100692.
Crossref
G. Marvaso, G. Corrao, O. Oneta, M. Pepa, M. Zaffaroni, F. Corso, S. Gandini, A. Cecconi, D. Zerini, G. C. Mazzola, M. Augugliaro, M. Cossu Rocca, E. Verri, F. Cattani, F. La Fauci, L. Bergamaschi, S. Luzzago, A. F. Mistretta, G. Musi, F. Nolè, O. De Cobelli, R. Orecchia & B. A. Jereczek-Fossa. (2021) Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how?. Clinical and Translational Oncology 23:8, pages 1717-1726.
Crossref
Sean All, Aurelie Garant & Raquibul Hannan. (2021) Stereotactic Ablative Radiation (SAbR) for Oligometastatic RCC. Seminars in Radiation Oncology 31:3, pages 227-234.
Crossref
Arjun Sahgal, Joe H. Chang, Lijun Ma, Lawrence B. Marks, Michael T. Milano, Paul Medin, Andrzej Niemierko, Scott G. Soltys, Wolfgang A. Tomé, C. Shun Wong, Ellen Yorke, Jimm Grimm & Andrew Jackson. (2021) Spinal Cord Dose Tolerance to Stereotactic Body Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics 110:1, pages 124-136.
Crossref
Marco Paciotti, Andrew L. Schmidt, Praful Ravi, Rana R. McKay, Quoc-Dien Trinh & Toni K. Choueiri. (2021) Temporal Trends and Predictors in the Use of Stereotactic Body Radiotherapy for Treatment of Metastatic Renal Cell Carcinoma in the U.S. The Oncologist 26:5, pages e905-e906.
Crossref
Darren Ming‐Chun Poon, Chun‐Ki Chan, Kuen Chan, Wing‐Hong Chu, Philip Wai‐Kay Kwong, Wayne Lam, Ka‐Suet Law, Eric Ka‐Chai Lee, Pak‐Ling Liu, Henry Chun‐Kin Sze, Joseph Hon‐Ming Wong & Eddie Shu‐Yin Chan. (2021) Consensus statements on the management of metastatic renal cell carcinoma from the Hong Kong Urological Association and the Hong Kong Society of Uro‐Oncology 2019. Asia-Pacific Journal of Clinical Oncology 17:S3, pages 27-38.
Crossref
Charles Marchand Crety, Estelle Vigneau & Camille Invernizzi. (2021) Stereotactic Body Radiotherapy of a Solitary Metachronous Sphenoid Metastasis from Renal Cell Cancer: A Case Report. Case Reports in Oncology 14:1, pages 269-273.
Crossref
Andrew L. Schmidt, Alexandra L. Tabakin, Eric A. Singer, Toni K. Choueiri & Rana R. McKay. (2021) Next Steps: Sequencing Therapies in Metastatic Kidney Cancer in the Contemporary Era. American Society of Clinical Oncology Educational Book:41, pages 187-197.
Crossref
Severin Rodler, Melanie Schott, Alexander Tamalunas, Julian Marcon, Annabel Graser, Jan-Niclas Mumm, Jozefina Casuscelli, Christian G. Stief, Christoph Fürweger, Alexander Muacevic & Michael Staehler. (2021) Safety and Efficacy of Robotic Radiosurgery for Visceral and Lymph Node Metastases of Renal Cell Carcinoma: A Retrospective, Single Center Analysis. Cancers 13:4, pages 680.
Crossref
M. Stenman, H. Benmakhlouf, P. Wersäll, P. Johnstone, M. A. Hatiboglu, J. Mayer-da-Silva, U. Harmenberg, M. Lindskog & G. Sinclair. (2020) Metastatic renal cell carcinoma to the brain: optimizing patient selection for gamma knife radiosurgery. Acta Neurochirurgica 163:2, pages 333-342.
Crossref
Michael Dohopolski, Raquibul Hannan, Zabi Wardak, Hans Hammers & Aurelie Garant. (2020) The Reintroduction of Radiotherapy Into the Integrated Management of Kidney Cancer. The Cancer Journal 26:5, pages 448-459.
Crossref
Joseph A. Miccio, Oluwadamilola T. Oladeru, Sung Jun Ma & Kimberly L. Johung. (2020) Radiation Therapy for Patients with Advanced Renal Cell Carcinoma. Urologic Clinics of North America 47:3, pages 399-411.
Crossref
Sara Omid, Mohammad Abufaraj & Mesut Remzi. (2020) Metastasectomy in patients with renal cell carcinoma: when and how?. Current Opinion in Urology 30:4, pages 602-609.
Crossref
Yuanyuan Zhang, Jonathan Schoenhals, Alana Christie, Osama Mohamad, Chiachien Wang, Isaac Bowman, Nirmish Singla, Hans Hammers, Kevin Courtney, Aditya Bagrodia, Vitaly Margulis, Neil Desai, Aurelie Garant, Hak Choy, Robert Timmerman, James Brugarolas & Raquibul Hannan. (2019) Stereotactic Ablative Radiation Therapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer. International Journal of Radiation Oncology*Biology*Physics 105:2, pages 367-375.
Crossref
Neha Vapiwala, Charles R. ThomasJr.Jr., Surbhi Grover, Mei Ling Yap, Timur Mitin, Lawrence N. Shulman, Mary K. Gospodarowicz, John Longo, Daniel G. Petereit, Ronald D. Ennis, James A. Hayman, Danielle Rodin, Jeffrey C. Buchsbaum, Bhadrasain Vikram, May Abdel-Wahab, Alan H. Epstein, Paul Okunieff, Joel Goldwein, Patrick Kupelian, Joanne B. Weidhaas, Margaret A. Tucker, John D. BoiceJr.Jr., Clifton David Fuller, Reid F. Thompson, Andrew D. Trister, Silvia C. Formenti, Mary-Helen Barcellos-Hoff, Joshua Jones, Kavita V. Dharmarajan, Anthony L. Zietman & C. Norman Coleman. (2019) Enhancing Career Paths for Tomorrow's Radiation Oncologists. International Journal of Radiation Oncology*Biology*Physics 105:1, pages 52-63.
Crossref
Nicholas G. Zaorsky, Eric J. Lehrer, Gargi Kothari, Alexander V. Louie & Shankar Siva. (2019) Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies. European Urology Oncology 2:5, pages 515-523.
Crossref
Guillaume Klausner, Idriss Troussier, Julian Biau, Julian Jacob, Antoine Schernberg, Charles-Henri Canova, Jean-Marc Simon, Pierre-Yves Borius, Gabriel Malouf, Jean-Philippe Spano, Morgan Roupret, Philippe Cornu, Jean-Jacques Mazeron, Charles Valéry, Loïc Feuvret & Philippe Maingon. (2019) Stereotactic Radiation Therapy for Renal Cell Carcinoma Brain Metastases in the Tyrosine Kinase Inhibitors Era: Outcomes of 120 Patients. Clinical Genitourinary Cancer 17:3, pages 191-200.
Crossref
Nikolaos Tselis & Georgios Chatzikonstantinou. (2019) Treating the Chameleon: Radiotherapy in the management of Renal Cell Cancer. Clinical and Translational Radiation Oncology 16, pages 7-14.
Crossref
Carole Mercier, Piet Dirix, Paul Meijnders, Peter Vermeulen, Steven Van Laere, Hilde Debois, Philippe Huget & Dirk Verellen. (2018) A phase I dose-escalation trial of stereotactic ablative body radiotherapy for non-spine bone and lymph node metastases (DESTROY-trial). Radiation Oncology 13:1.
Crossref
Rohann J. M. Correa, Belal Ahmad, Andrew Warner, Craig Johnson, Mary J. MacKenzie, Stephen E. Pautler, Glenn S. Bauman, George B. Rodrigues & Alexander V. Louie. (2018) A prospective phase I dose-escalation trial of stereotactic ablative radiotherapy (SABR) as an alternative to cytoreductive nephrectomy for inoperable patients with metastatic renal cell carcinoma. Radiation Oncology 13:1.
Crossref
Benoîte Mery, Chloé Rancoule, Elise Rowinski, Claire Bosacki, Alexis Vallard, Jean-Baptiste Guy & Nicolas Magné. (2018) Cancer du rein et radiothérapie : radiorésistance et au-delà. Bulletin du Cancer 105, pages S280-S285.
Crossref
S. Rieken & R. El Shafie. (2018) Kombinationen von Strahlen- und Immuntherapie für urologische TumorerkrankungenCombining radiotherapy with immunotherapy for urological malignancies. Der Urologe 57:11, pages 1309-1315.
Crossref
Sarah P. Psutka & Viraj A. Master. (2018) Role of metastasis‐directed treatment in kidney cancer. Cancer 124:18, pages 3641-3655.
Crossref
Consuelo Buttigliero, Simona Allis, Marcello Tucci, Clizia Zichi, Gianmarco Leone, Rosario Francesco Di Stefano, Maria Grazia Ruo Redda, Umberto Ricardi, Giorgio Vittorio Scagliotti, Massimo Di Maio & Andrea Riccardo Filippi. (2018) Role of radiotherapy in improving activity of immune-modulating drugs in advanced renal cancer: Biological rationale and clinical evidences. Cancer Treatment Reviews 69, pages 215-223.
Crossref
Francesca De Felice & Vincenzo Tombolini. (2018) Radiation therapy in renal cell carcinoma. Critical Reviews in Oncology/Hematology 128, pages 82-87.
Crossref
Emmanuel Meyer, David Pasquier, Guillemette Bernadou, Gilles Calais, Pierre Maroun, Alberto Bossi, Christine Theodore, Laurence Albiges, Dinu Stefan, Renaud de Crevoisier, Christophe Hennequin, Jean-Léon Lagrange, Jean-Michel Grellard, Bénédicte Clarisse, Idlir Licaj, Jean-Louis Habrand, Christian Carrie & Florence Joly. (2018) Stereotactic radiation therapy in the strategy of treatment of metastatic renal cell carcinoma: A study of the Getug group. European Journal of Cancer 98, pages 38-47.
Crossref
Štefan Reguli, Jakub Cvek, Radim Lipina, Jan Krajča, Natálie Stieberová, Přemysl Dobeš & Lukáš Knybel. (2018) CyberKnife in treatment brain metastases. Onkologie 12:3, pages 130-138.
Crossref
Rohann J.M. Correa, George B. Rodrigues, Hanbo Chen, Andrew Warner, Belal Ahmad & Alexander V. Louie. (2018) Stereotactic Ablative Radiotherapy (SABR) for Large Renal Tumors. American Journal of Clinical Oncology 41:6, pages 568-575.
Crossref
M. Stenman, G. Sinclair, P. Paavola, P. Wersäll, U. Harmenberg & M. Lindskog. (2018) Overall survival after stereotactic radiotherapy or surgical metastasectomy in oligometastatic renal cell carcinoma patients treated at two Swedish centres 2005–2014. Radiotherapy and Oncology 127:3, pages 501-506.
Crossref
Waqar Haque, Vivek Verma, Gary D Lewis, Simon S Lo, Edward Brian Butler & Bin S Teh. (2018) Utilization of radiotherapy and stereotactic body radiation therapy for renal cell cancer in the USA. Future Oncology 14:9, pages 819-827.
Crossref
Annelies Verbiest, Gert De Meerleer, Maarten Albersen & Benoit Beuselinck. (2018) Non-Surgical Ablative Treatment of Distant Extracranial Metastases for Renal Cell Carcinoma: A Systematic Review. Kidney Cancer 2:1, pages 57-67.
Crossref
Rohit Gunan Ganju, Mindi TenNapel, Nicholas Mahan, Amir Zahra & Xinglei Shen. (2018) The Efficacy of Conventionally Fractionated Radiation in the Management of Osseous Metastases from Metastatic Renal Cell Carcinoma. Journal of Oncology 2018, pages 1-7.
Crossref
Michael A. Garcia & Alexander R. Gottschalk. 2018. Handbook of Evidence-Based Radiation Oncology. Handbook of Evidence-Based Radiation Oncology 535 543 .
Nikolaos Tselis & Georgios Chatzikonstantinou. 2018. Radiation Oncology. Radiation Oncology 1 14 .
Katrien De Wolf, Sylvie Rottey, Karim Vermaelen, Karel Decaestecker, Nora Sundahl, Lizzy De Lobel, Els Goetghebeur, Gert De Meerleer, Nicolaas Lumen, Valérie Fonteyne, Daan De Maeseneer & Piet Ost. (2017) Combined high dose radiation and pazopanib in metastatic renal cell carcinoma: a phase I dose escalation trial. Radiation Oncology 12:1.
Crossref
Shankar Siva, Daniel Pham, Tomas Kron, Mathias Bressel, Jacqueline Lam, Teng Han Tan, Brent Chesson, Mark Shaw, Sarat Chander, Suki Gill, Nicholas R. Brook, Nathan Lawrentschuk, Declan G. Murphy & Farshad Foroudi. (2017) Stereotactic ablative body radiotherapy for inoperable primary kidney cancer: a prospective clinical trial. BJU International 120:5, pages 623-630.
Crossref
Shankar Siva, Gargi Kothari, Alexander Muacevic, Alexander V. Louie, Ben J. Slotman, Bin S. Teh & Simon S. Lo. (2017) Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach. Nature Reviews Urology 14:9, pages 549-563.
Crossref
Shankar Siva, Jason Callahan, David Pryor, Jarad Martin, Nathan Lawrentschuk & Michael S Hofman. (2017) Utility of 68 Ga prostate specific membrane antigen - positron emission tomography in diagnosis and response assessment of recurrent renal cell carcinoma . Journal of Medical Imaging and Radiation Oncology 61:3, pages 372-378.
Crossref
Arnaldo Marín, Alex Renner, Laura Itriago & Manuel Álvarez. (2017) METÁSTASIS CEREBRALES: UNA MIRADA BIOLÓGICA Y CLÍNICA. Revista Médica Clínica Las Condes 28:3, pages 437-449.
Crossref
Daniel P. Milgrom, Neha L. Lad, Leonidas G. Koniaris & Teresa A. Zimmers. (2017) Bone Pain and Muscle Weakness in Cancer Patients. Current Osteoporosis Reports 15:2, pages 76-87.
Crossref
Ibiayi Dagogo-Jack, Corey M. Gill, Daniel P. Cahill, Sandro Santagata & Priscilla K. Brastianos. (2017) Treatment of brain metastases in the modern genomic era. Pharmacology & Therapeutics 170, pages 64-72.
Crossref
Yun Jong ChoiJin Ho LeeCho Rok LeeWoong Kyu HanChang Moo KangWoo Jung Lee. (2017) Laparoscopic total pancreatectomy for multiple metastasis of renal cell carcinoma of the pancreas: a case report and literature review. Annals of Hepato-Biliary-Pancreatic Surgery 21:2, pages 96.
Crossref
Gargi Kothari, Simon S. Lo, Matthew Foote, Arjun Sahgal, Irene Karam, Michael Lock, Gerrit J. Blom, Matthias Guckenberger, Ben J. Slotman & Shankar Siva. 2018. Alternate Fractionation in Radiotherapy. Alternate Fractionation in Radiotherapy 323 395 .
Cédric Panje, Nikolaus Andratschke, Thomas B. Brunner, Maximilian Niyazi & Matthias Guckenberger. (2016) Stereotactic body radiotherapy for renal cell cancer and pancreatic cancerKörperstereotaxie beim Nierenzell- und Pankreaskarzinom. Strahlentherapie und Onkologie 192:12, pages 875-885.
Crossref
Saeed Dabestani, Lorenzo Marconi & Axel Bex. (2016) Metastasis therapies for renal cancer. Current Opinion in Urology 26:6, pages 566-572.
Crossref
S Ahmad, P Zakikhani, W Gietzman, G Macdonald & JS Royle. (2016) Radiation therapy for urological cancers. Journal of Clinical Urology 9:3, pages 142-150.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.